Birdwatch Note Rating
2024-05-01 03:18:21 UTC - HELPFUL
Rated by Participant: 9A457CC2826AECEF1D5BF6EED17FFBB9E34FDBA0E347826681EB6F97022540B5
Participant Details
Original Note:
EBC-46 is a compound with potential anti-cancer properties that has been successfully used in veterinary medicine and is currently being studied for use in humans. However, the claim of it killing cancer in 48 hours should be viewed in the context of ongoing research. https://news.stanford.edu/2022/10/03/breakthrough-production-acclaimed-cancer-treating-drug/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268252/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182759/ https://www.europeanpharmaceuticalreview.com/news/175005/novel-cancer-therapeutic-synthesised-by-stanford-researchers/
All Note Details